Skip to main content

This job has expired

Head of Medical Affairs

Employer
Seagen
Location
Bothell, Washington State
Salary
Market Rate
Closing date
Jun 30, 2019

Job Details

Summary: 

The Head of Medical Affairs leads a 60 person Medical Affairs function in support of all approved and late-stage development compounds, including ADCETRIS, enfortumab vedotin (EV), tisotumab vedotin (TV), tucatinib, and ladiratuzumab vedotin (LIV1A),  in the US, Europe and globally, while providing strategic input and operational support for our growing early pipeline of oncology assets. This highly influential and communicative physician-scientist will work across the Research, Clinical Development and Commercial organizations, building a strong link between clinical development and commercial operations.  As a member of the company’s governance bodies for research, clinical development, and commercial, the Head of Medical Affairs is expected to influence a wide range of scientific and business decisions regarding the strategic direction of ADCETRIS, as well as the company’s clinical development programs.  

 

Responsibilities: 

  • Management oversight of Medical Affairs team to ensure consistency and optimal performance through appropriate metrics
  • Involvement with the commercial and clinical development organizations to review, approve and track results from approved business and development plans
  • Works closely with Medical Affairs colleagues in partner companies to ensure Medical Affairs strategies and business plans are aligned globally
  • Acts as the primary Medical Affairs representative with governmental agencies (including regulatory and reimbursement entities), professional associations and special interest groups, fostering the establishment and maintenance of external scientific advisory boards, while assisting in advocacy development
  • Secures high ethical standards/compliance in all Medical Affairs activities, positioning Seattle Genetics as a world-class science-driven leader amongst medical societies and communities
  • Develops strategy for and supervises evaluation of all investigator-sponsored trials, including intake, contracting, and monitoring
  • Oversees Medical Affairs operations & publications; work with brand teams to design publication strategy, coordinating, and executing communications. Responsible for approval of all promotional material, in compliance with corporate standards and government/industry regulations
  • Defines medical education and key opinion leader development strategy, while providing direction to the Medical Science Liaisons
  • Demonstrates a high level of commercial orientation, establishing Medical Affairs as a value-adding partner to Marketing and Sales, providing quantifiably constructive input to product/marketing strategies and operational plans
  • Enhances functional competencies in Medical Affairs to monitor and quickly adjust to changes in Seattle Genetics’ key therapeutic areas, with an ability to pro-actively navigate and provide competitive intelligence
  • Builds on existing resources to create a highly energized, top-performing Medical Affairs team, through internal relationship and alliance development, ultimately gaining support and buy-in from the team in order to execute the overall Medical Affairs strategy
  • Encourages a dynamic work environment that supports the company’s vision of improving the lives of people with cancer while also living our values

 

Experience: 

  • Must be a seasoned Medical Affairs leader who has overseen a Medical Affairs team, with deep functional and technical expertise. Ideally possessing oncology launch, post-marketing, and life cycle management expertise
  • A minimum of 10 years of direct experience in combined Medical Affairs and/or late-stage clinical development positions of increasing complexity and breadth. Must have spent a significant portion of that time in Medical Affairs
  • A proven leader who can inspire and engage a team of highly skilled and educated professionals located throughout the country.  Must also demonstrate the ability to collaborate with and influence executives across many different departments and functions in order to reach effective decisions on medical, scientific, commercial and organizational endeavors
  • MD and/or MD/PhD from an accredited institution is preferred; however, a Pharm D or PhD with significant Medical Affairs and clinical experience would also be considered. Oncology and/or immunology background is highly preferred.  Likewise, board certification and significant prior clinical experience is preferable
  • A solid understanding of relevant regulatory requirements, particularly related to post-marketing medical activities
  • Ideal candidate will have big pharma / biotech experience (as a training ground), and can demonstrate the ability to roll up one’s sleeves, working creatively, resourcefully, and expeditiously
  • Preferably, experience within a development stage and/or small to mid-cap biotechnology company
  • Podium presence and exceptional writing capabilities required
  • Access to key thought leaders, with a substantial professional network that has continued to evolve over time

 

As the leading employer in our industry in the Pacific Northwest, Seattle Genetics is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seattle Genetics, please visit www.seattlegenetics.com.

Seattle Genetics is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law.

Company

Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer.

As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology.

We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.

Company info
Website

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert